Lista de obras - Daisuke Yabe - Dominio Público Uruguay

A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion

artículo científico publicado en 2008

A case of hypoglycemia due to illegitimate sexual enhancement medication

artículo científico publicado en 2015

Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice

artículo científico publicado en 2007

Alogliptin benzoate for the treatment of type 2 diabetes

artículo científico

Alogliptin for the treatment of Type 2 diabetes

scientific article published on 11 October 2014

Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation

artículo científico publicado en 2015

Association of Glucagon-like Peptide-1 Receptor (GLP-1R)-targeted Imaging Probe with In-vivo GLP-1R Agonist Glucose-lowering Effects

artículo científico publicado en 2020

Beta-cell replacement strategies for diabetes

artículo científico publicado en 2017

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases

artículo científico publicado en 2017

Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology

artículo científico publicado en 2019

Calumenin, a Ca2+-binding Protein Retained in the Endoplasmic Reticulum with a Novel Carboxyl-terminal Sequence, HDEF ⬇️

artículo científico publicado el 18 de julio de 1997

Cardioprotective effects of GLP-1(28-36a): A degraded metabolite or GLP-1's better half?

scientific article published on 19 May 2020

Cardiovascular safety trials of incretin-based drugs: What do they mean?

artículo científico publicado en 2016

Ceritinib-associated hyperglycemia in the Japanese Adverse Drug Event Report Database

artículo científico publicado en 2019

Circadian rhythms and diabetes.

artículo científico publicado en 2011

Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes

artículo científico publicado en 2013

Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects

artículo científico publicado en 2014

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

artículo científico publicado en 2012

Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER

artículo científico publicado en 2002

DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries

artículo científico publicado en 1999

Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetes

scientific article published on 03 September 2014

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia

scientific article published on 23 September 2019

Dipeptidyl peptidase-4 inhibitors and prevention of bone fractures: Effects beyond glyemic control

artículo científico publicado en 2012

Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?

artículo científico publicado en 2014

Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

artículo científico publicado en 2012

Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin

artículo científico publicado en 2012

Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients

artículo científico publicado en 2014

Effect of hypertriglyceridemia in dyslipidemia-induced impaired glucose tolerance and sex differences in dietary features associated with hypertriglyceridemia among the Japanese population: The Gifu Diabetes Study

artículo científico publicado en 2020

Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study

artículo científico publicado en 2015

Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S

artículo científico publicado en 2014

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial).

artículo científico publicado en 2017

Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials

scientific article published on 24 May 2016

Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

artículo científico publicado en 2016

Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo

artículo científico publicado en 2013

Evidence-based practice guideline for the treatment for diabetes in Japan 2013

article

Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea

artículo científico publicado en 2014

Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase

artículo científico publicado en 2009

GIP and GLP-1, the two incretin hormones: Similarities and differences

artículo científico publicado en 2010

GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells

artículo científico publicado en 2019

Generation of a conditional knockout allele for mammalian Spen protein Mint/SHARP.

artículo científico publicado en 2007

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

artículo científico publicado en 1998

Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points.

artículo científico publicado en 2015

Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener

artículo científico publicado en 2012

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

artículo científico publicado en 2013

Human Calumenin Gene (CALU): cDNA Isolation and Chromosomal Mapping to 7q32 ⬇️

artículo científico publicado el 15 de abril de 1998

Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity

artículo científico publicado en 2013

Incretin actions beyond the pancreas: lessons from knockout mice

artículo científico publicado en 2013

Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?

artículo científico publicado en 2017

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

artículo científico publicado en 2016

Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas

artículo científico publicado en 2005

Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol

artículo científico publicado en 2003

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.

artículo científico publicado en 2015

Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese

artículo científico publicado en 2012

Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes

artículo científico publicado en 2009

Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference ⬇️

artículo científico publicado el 13 de septiembre de 2011

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

artículo científico publicado en 2010

Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis

artículo científico publicado en 2003

Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan.

artículo científico publicado en 2015

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial

artículo científico publicado en 2015

Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan

scientific article published on 01 April 2018

Molecular cloning, characterization, and chromosomal localization of FKBP23, a novel FK506-binding protein with Ca2+-binding ability

scientific journal article

Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling

artículo científico publicado en 2007

Multiple roles of Notch signaling in cochlear development

artículo científico publicado en 2007

Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas

scientific article published on 01 January 2006

Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels

artículo científico publicado en 2012

Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors

artículo científico publicado en 2020

Rbp-j regulates expansion of pancreatic epithelial cells and their differentiation into exocrine cells during mouse development

artículo científico publicado en 2007

Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus.

artículo científico publicado en 2014

Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.

artículo científico publicado en 2017

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year afte

artículo científico publicado en 2018

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

artículo científico publicado en 2017

Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function.

artículo científico publicado en 2013

Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation.

artículo científico publicado en 2015

Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials

artículo científico publicado en 2018

Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events

artículo científico publicado en 2015

Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: potential mechanism of resistance to weight loss among Japanese obese smokers

artículo científico publicado en 2012

Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation.

artículo científico publicado en 2017

Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.

artículo científico publicado en 2016

Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label,

artículo científico publicado en 2017

Sodium-glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report

scientific article published on 03 September 2019

The Asian Association for the Study of Diabetes (AASD): The first ten years and the next ten years

scientific article published on 10 July 2020

The Role of Metagenomics in Precision Nutrition

artículo científico publicado en 2020

The journey to understanding incretin systems: Theory, practice and more theory

scientific article published on 20 August 2019

The role of family nutritional support in Japanese patients with type 2 diabetes mellitus

artículo científico publicado en 2010

Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols.

artículo científico publicado en 2002

Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus.

artículo científico publicado en 2014

Tumor-like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin-induced insulin secretion in obese diabetes: a study of ZFDM rat

scientific article published on 11 April 2020

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity

artículo científico publicado en 2019

Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.

artículo científico

Type 2 diabetes via β-cell dysfunction in east Asian people

artículo científico publicado en 2015

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs

artículo científico publicado en 2014

β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians

artículo científico publicado en 2015

Lista de obras de Daisuke Yabe

A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion

A case of hypoglycemia due to illegitimate sexual enhancement medication

Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice

Alogliptin benzoate for the treatment of type 2 diabetes

Alogliptin for the treatment of Type 2 diabetes

Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation

Association of Glucagon-like Peptide-1 Receptor (GLP-1R)-targeted Imaging Probe with In-vivo GLP-1R Agonist Glucose-lowering Effects

Beta-cell replacement strategies for diabetes

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases

Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology

Calumenin, a Ca2+-binding Protein Retained in the Endoplasmic Reticulum with a Novel Carboxyl-terminal Sequence, HDEF ⬇️

Cardioprotective effects of GLP-1(28-36a): A degraded metabolite or GLP-1's better half?

Cardiovascular safety trials of incretin-based drugs: What do they mean?

Ceritinib-associated hyperglycemia in the Japanese Adverse Drug Event Report Database

Circadian rhythms and diabetes.

Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes

Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER

DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries

Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetes

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia

Dipeptidyl peptidase-4 inhibitors and prevention of bone fractures: Effects beyond glyemic control

Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?

Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin

Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients

Effect of hypertriglyceridemia in dyslipidemia-induced impaired glucose tolerance and sex differences in dietary features associated with hypertriglyceridemia among the Japanese population: The Gifu Diabetes Study

Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study

Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial).

Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials

Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo

Evidence-based practice guideline for the treatment for diabetes in Japan 2013

Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea

Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase

GIP and GLP-1, the two incretin hormones: Similarities and differences

GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells

Generation of a conditional knockout allele for mammalian Spen protein Mint/SHARP.

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points.

Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

Human Calumenin Gene (CALU): cDNA Isolation and Chromosomal Mapping to 7q32 ⬇️

Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity

Incretin actions beyond the pancreas: lessons from knockout mice

Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas

Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.

Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese

Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes

Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference ⬇️

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis

Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan.

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial

Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan

Molecular cloning, characterization, and chromosomal localization of FKBP23, a novel FK506-binding protein with Ca2+-binding ability

Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling

Multiple roles of Notch signaling in cochlear development

Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas

Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels

Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors

Rbp-j regulates expansion of pancreatic epithelial cells and their differentiation into exocrine cells during mouse development

Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus.

Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year afte

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function.

Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation.

Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials

Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events

Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: potential mechanism of resistance to weight loss among Japanese obese smokers

Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation.

Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.

Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label,